Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India
· Delayed Price · Currency is INR 72.00
-3.34 (-4.43%)
May 9, 2025, 1:39 PM IST
Bafna Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 73.48 | 113.38 | 52.16 | 58.27 | -252.04 | Upgrade
|
| Depreciation & Amortization | 49.95 | 53.34 | 54.93 | 44.78 | 32.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.66 | -1.96 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -233.26 | Upgrade
|
| Provision & Write-off of Bad Debts | 6 | 6.73 | - | - | - | Upgrade
|
| Other Operating Activities | 18.87 | 22.24 | -1.86 | -6.61 | 231.66 | Upgrade
|
| Change in Accounts Receivable | -48.46 | -270.42 | -61.12 | -35.25 | 187.99 | Upgrade
|
| Change in Inventory | -74.23 | -19.39 | -48.37 | -40.31 | -21.29 | Upgrade
|
| Change in Accounts Payable | 69.62 | 160.56 | 122.18 | -18.5 | -268.83 | Upgrade
|
| Change in Other Net Operating Assets | 0.28 | -14.95 | -20.64 | -138.48 | -19.58 | Upgrade
|
| Operating Cash Flow | 94.85 | 49.53 | 97.28 | -136.09 | -342.68 | Upgrade
|
| Operating Cash Flow Growth | 91.52% | -49.09% | - | - | - | Upgrade
|
| Capital Expenditures | -155.78 | -67.19 | -75.41 | -60.95 | -14.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.71 | 1.96 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2.7 | -15 | - | - | - | Upgrade
|
| Other Investing Activities | 6.24 | 5.29 | 9.97 | 7.49 | 12.5 | Upgrade
|
| Investing Cash Flow | -150.54 | -74.93 | -65.44 | -53.45 | 327.75 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 98.68 | - | Upgrade
|
| Long-Term Debt Issued | 14.65 | 118.65 | - | 25 | - | Upgrade
|
| Total Debt Issued | 14.65 | 118.65 | - | 123.68 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -232.4 | Upgrade
|
| Long-Term Debt Repaid | - | - | -47.27 | - | -200.01 | Upgrade
|
| Total Debt Repaid | - | - | -47.27 | - | -432.4 | Upgrade
|
| Net Debt Issued (Repaid) | 14.65 | 118.65 | -47.27 | 123.68 | -432.4 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 553.56 | Upgrade
|
| Other Financing Activities | -23.11 | -16.87 | -0.88 | -0.89 | -48.44 | Upgrade
|
| Financing Cash Flow | -8.45 | 101.77 | -48.15 | 122.8 | 72.71 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0.02 | 0 | Upgrade
|
| Net Cash Flow | -64.14 | 76.36 | -16.31 | -66.76 | 57.78 | Upgrade
|
| Free Cash Flow | -60.93 | -17.66 | 21.87 | -197.04 | -356.97 | Upgrade
|
| Free Cash Flow Margin | -4.00% | -1.53% | 2.57% | -27.67% | -84.05% | Upgrade
|
| Free Cash Flow Per Share | -2.58 | -0.75 | 0.93 | -8.32 | -150.90 | Upgrade
|
| Cash Interest Paid | 23.11 | 16.87 | 0.88 | 0.89 | 0.96 | Upgrade
|
| Cash Income Tax Paid | 1.74 | 1.28 | 1.7 | - | - | Upgrade
|
| Levered Free Cash Flow | -131.35 | -97.3 | 13.94 | -215.85 | -115.24 | Upgrade
|
| Unlevered Free Cash Flow | -119.24 | -86.07 | 17.22 | -215.29 | -115.24 | Upgrade
|
| Change in Net Working Capital | 51.1 | 130.8 | 3.81 | 237.54 | 121.27 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.